CSIFX
Price
$46.88
Change
+$0.24 (+0.51%)
Updated
Aug 6 closing price
Net Assets
1.43B
RLBCX
Price
$36.79
Change
-$0.02 (-0.05%)
Updated
Aug 7 closing price
Net Assets
253.12B
Interact to see
Advertisement

CSIFX vs RLBCX

Header iconCSIFX vs RLBCX Comparison
Open Charts CSIFX vs RLBCXBanner chart's image
Calvert Balanced A
Price$46.88
Change+$0.24 (+0.51%)
VolumeN/A
Net Assets1.43B
American Funds American Balanced R3
Price$36.79
Change-$0.02 (-0.05%)
VolumeN/A
Net Assets253.12B
CSIFX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CSIFX vs. RLBCX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSIFX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 253B vs. CSIFX (1.43B). RLBCX pays higher dividends than CSIFX: RLBCX (1.56) vs CSIFX (1.30). CSIFX was incepted earlier than RLBCX: CSIFX (43 years) vs RLBCX (23 years). CSIFX (0.90) and RLBCX (0.89) have similar cost to investors . CSIFX is a more actively managed with annual turnover of: 153.00 vs. RLBCX (44.00). RLBCX has a lower initial minimum investment than CSIFX: RLBCX (250) vs CSIFX (1000). RLBCX annual gain was more profitable for investors over the last year : 11.04 vs. CSIFX (10.26). RLBCX (34.79) and CSIFX (34.60) have equivalent 5 years return.
CSIFXRLBCXCSIFX / RLBCX
Total Expense Ratio0.900.89101%
Annual Report Gross Expense Ratio0.900.89101%
Fund Existence43 years23 years-
Gain YTD5.7338.35969%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.43B253B1%
Annual Yield % from dividends1.301.5684%
Returns for 1 year10.2611.0493%
Returns for 3 years32.9329.84110%
Returns for 5 years34.6034.7999%
Returns for 10 years57.6260.6595%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APRE1.650.01
+0.61%
Aprea Therapeutics
CFG46.64-0.29
-0.62%
Citizens Financial Group
CMPS4.31-0.05
-1.15%
COMPASS Pathways Plc
CNTB2.07-0.06
-2.82%
Connect Biopharma Holdings Limited
LRN144.05-4.27
-2.88%
Stride